# In Ovo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/in-ovo-b-v

- Industry: Agribusiness
- Headquarters: Leiden, Netherlands
- Website: www.inovo.nl
- Total disclosed funding: $37M
- Latest round: Series B (Mar 2, 2022)
- Investors on record: 7

## About

Based in Leiden, Netherlands, and founded in 2013 by Co-founder Wouter Bruins and Co-founder Wil Stutterheim, operates as an ag-tech provider of solutions for the culling of chicks using biotechnology for the poultry industry and improving animal welfare. In March 2022, In Ovo B.V. raised EUR 34 million in series B funding led by ECBF, with participation from ABN AMRO, DEMCON, and Libertatis Ergo Holding B.V. Evonik Venture Capital and Visvires New Protein also participated in the round. 

The company provides Ella which is a machine that identifies the gender of an egg instead of a chick, ensuring only females are hatched, for preventing the culling of male chicks. The firm can identify the gender of an egg on day 9 of the incubation period. 

The company will use its proceedings to accelerate international growth and scale up its screening machine, Ella for advancing global animal welfare and sustainability of the poultry industry.

## Funding rounds

- Series B, Mar 2, 2022, $37M — ABN AMRO, DEMCON, Clay Capital, Evonik Venture Capital, Libertatis Ergo Holding B.V., ECBF
- Series A, Oct 29, 2018 — Clay Capital, Evonik Venture Capital, Leiden University

## Investors

- Clay Capital (https://capitalatlas.ai/funds/clay-capital) — Series A, Series B
- Evonik Venture Capital (https://capitalatlas.ai/funds/evonik-venture-capital) — Series A, Series B
- Leiden University — Series A
- ABN AMRO (https://capitalatlas.ai/funds/abn-amro) — Series B
- DEMCON — Series B
- Libertatis Ergo Holding B.V. — Series B
- ECBF (https://capitalatlas.ai/funds/ecbf) — Series B